Previous 10 | Next 10 |
A couple of retailers saw their stocks plummet in Tuesday's pre-market action despite quarterly earnings that nominally beat expectations. Best Buy (NYSE:BBY) and Urban Outfitters (NASDAQ:URBN) posted double-digit percentage declines on signs that sales won't be able to keep up their recent b...
SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 PR Newswire NEW YORK , Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: S...
Emergent BioSolutions (NYSE:EBS) will leave the S&P MidCap 400 and join the S&P SmallCap 600, prior to the beginning of trading on Nov. 30. Emergent shares are down 55% year-to-date, as the company has been hurt by vaccine manufacturing issues at its Baltimore plant. Earlier...
The modification/loss of a contract coupled with a weak earnings report sent the stock tumbling 40%. We jumped on this overreaction for a quick gain, but now see the stock rallying further into 2022 on some bullish developments. The company is anticipating a significant top-line r...
It's always pleasant when one of our stocks pays us rather than the other way around. Such is the case with vaccine and antibody company Emergent BioSolutions (NYSE: EBS) , which closed Friday more than 4% higher after it announced it would open its wallet to buy shares of its own e...
Emergent BioSolutions (NYSE:EBS) is trading ~4.4% higher after the company announced an authorization to repurchase up to $250M of the company’s common stock. Based on market conditions and other factors, the buybacks will be carried out from time to time on the open mar...
GAITHERSBURG, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized management to repurchase up to $250 million of the company's common stock from time to time on the open market or in privatel...
After securing its first EUA from the Republic of Indonesia, Novavax is poised to receive a string of use authorizations from a variety of centers around the globe. The company has lined up myriad fill/finish facilities across the globe and authorized exclusive licensing agreements wi...
The FDA has greenlighted two additional COVID-19 vaccine batches manufactured by Emergent Biosolutions (NYSE:EBS) for Johnson & Johnson (NYSE:JNJ). The regulator has determined that the batches were safe for use following a thorough review and considering the requirements during...
Earnings news remained the crucial driver during Friday's midday action. Airbnb (NASDAQ:ABNB), Pinterest (NYSE:PINS) and Uber (NYSE:UBER) all showed notable gains following the release of their quarterly reports. Elsewhere, Emergent (NYSE:EBS) lost about two-fifths of its value after disclosi...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...